Shanghai Pharmaceuticals Holding Co., Ltd. — Proxy Solicitation & Information Statement 2025

Feb 21, 2025

SPH 上海医药 SHANGHAI PHARMA

上海醫藥集團股份有限公司

Shanghai Pharmaceuticals Holding Co., Ltd.*

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 02607)

REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE EXTRAORDINARY GENERAL MEETING

To: Shanghai Pharmaceuticals Holding Co., Ltd.* (the "Company")

Name of shareholder and registered address (Note 1): _______

being registered holder of (Note 2) _______ H shares.

I/We intend to attend (in person or by proxy) the Extraordinary General Meeting of the Company to be held at Meeting Room, 2nd Floor, Shanghai Pharma Building, 200 Taicang Road, Huangpu District, Shanghai, the PRC on 13 March 2025 at 14:00 and any adjournment thereof.

Signature of shareholder: _______

Name of shareholder: _______

Date: ___ 2025

Notes:

1. Please insert full name(s) (in Chinese or in English) and address(es) (as it is recorded in the register of members of the Company) in block letters.
2. Please insert the number of shares registered under your name(s).

3. For holders of H shares of the Company, the completed and signed reply slip should be delivered to the H Share Registrar of the Company, MUFG Corporate Markets Pty Limited, at Suite 1601, 16/F., Central Tower, 28 Queen's Road Central, Hong Kong on or before 3 March 2025 in person or by mail. In order to attend and vote at the Extraordinary General Meeting (or any adjournment thereof), holders of H Shares of the Company should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Company's H Share registrar, MUFG Corporate Markets Pty Limited, at Suite 1601, 16/F., Central Tower, 28 Queen's Road Central, Hong Kong not later than 16:30 on 7 March 2025.

4. For identification purpose only